Investigative Ophthalmology & Visual Science, Vol 38, 1526-1534, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Nonsulfhydryl-reactive phenoxyacetic acids increase aqueous humor outflow facility

DL Epstein, BC Roberts and LL Skinner
Department of Ophthalmology, Duke University Medical Center, Duke University Eye Center, Durham, North Carolina 27710, USA.

PURPOSE: The phenoxyacetic acid, ethacrynic acid (ECA), has potential use in glaucoma therapy because it acts to increase aqueous outflow in vivo and in vitro. In human trabecular meshwork (HTM) cell culture, ECA acts to change cell shape and attachment, effects that have been correlated with microtubule (MT) alterations and chemical sulfhydryl (SH) reactivity. To further explore these actions, we evaluated two non- SH reactive phenoxyacetic acids, inadcrinone and ticrynafen, and the MT- disrupting drug vinblastine. METHODS: Excised bovine and porcine eyes were perfused and outflow facility measured. Calf pulmonary artery endothelial and HTM cells were grown in culture and cytoskeletal effects evaluated after drug treatment. RESULTS: Indacrinone, ticrynafen, and vinblastine all caused an increase in outflow facility. In contrast with ECA, the outflow effects of indacrinone and ticrynafen were not blocked by excess cysteine. Although indacrinone and ticrynafen produced changes in cell shape in vitro, the beta-tubulin staining pattern of treated cells was not altered. Vinblastine caused cell shape change and the expected MT disruption. CONCLUSIONS: Phenoxyacetic acids can increase aqueous outflow facility and alter HTM cell shape and attachment in vitro by a non-SH, non-MT mechanism (which is probably shared also by ECA). These findings suggest the possibility of a broader class of glaucoma drugs that may be directed at the HTM. An understanding of the cellular target for these drugs has implications both for potential glaucoma therapy and for the cytoskeletal mechanisms involved in normal outflow function.

This article has been cited by other articles:

				Y. F. Njie, Z. Qiao, Z. Xiao, W. Wang, and Z.-H. Song N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4528 - 4534. [Abstract] [Full Text] [PDF]

				C.-W. Kong, K.-K. Li, and C.-H. To Chloride Secretion by Porcine Ciliary Epithelium: New Insight into Species Similarities and Differences in Aqueous Humor Formation Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5428 - 5436. [Abstract] [Full Text] [PDF]

				X. Zhao, K. E. Pearson, D. A. Stephan, and P. Russell Effects of Prostaglandin Analogues on Human Ciliary Muscle and Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 1945 - 1952. [Abstract] [Full Text] [PDF]

				P. V. Rao, P.-F. Deng, J. Kumar, and D. L. Epstein Modulation of Aqueous Humor Outflow Facility by the Rho Kinase-Specific Inhibitor Y-27632 Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1029 - 1037. [Abstract] [Full Text]

				P. Gonzalez, D. L. Epstein, and T. Borrás Genes Upregulated in the Human Trabecular Meshwork in Response to Elevated Intraocular Pressure Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 352 - 361. [Abstract] [Full Text]

				M. A. Croft, R. F. Wang, S. M. Podos, A. H. Neufeld, and P. L. Kaufman Effect of Ticrynafen on Aqueous Humor Dynamics in Monkeys Arch Ophthalmol, November 1, 1998; 116(11): 1481 - 1488. [Abstract] [Full Text] [PDF]